glp 1 gastric issues GLP-1 Medicines And Gut Bacterial Overgrowth How Do GLP-1 Medications Work?

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

This medication can also be beneficial for individuals with specific underlying medical conditions contributing to weight gain, such as Cushings syndrome, hypothyroidism, or certain genetic disorders

Indeed, these compounds exert numerous pleiotropic actions that favorably affect metabolism and diabetes comorbidities, showing an additional effect beyond glucose control

Shukla, A., L

Clinical trial data from the STEP 1 and SURMOUNT-1 trials show that patients typically achieve 1015% total body weight loss with semaglutide 2.4 mg weekly (Wegovy) and 1520% with tirzepatide 1015 mg weekly (Zepbound) over 1218 months

Disruption of this hub, via silencing of VAPB or SPHKAP, significantly blunts the ability of the receptor to potentiate insulin secretion and protect -cells from apoptosis (Austin et al., 2025)